As of November 6, 2026, Precigen, Inc. is a publicly traded company (Nasdaq: PGEN). The largest holder reporting an active stake on Schedule 13D is Randal J. Kirk, a director and 10% owner, at 35.9%. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13D/A, March 31, 2026).
Is this your company?
About to sign with, pay or invest in Precigen, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Precigen, Inc. a real, registered company?
- Precigen, Inc. files with the SEC under CIK 1356090 (its SEC filings).
- Its shares are listed under the ticker PGEN on Nasdaq (SEC company record).
- Incorporated in Virginia; business address in Germantown, Maryland, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Precigen, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Randal J. Kirk (filed 2026-03-31).
Who are Precigen, Inc.'s owners and officers?
Precigen, Inc.: incorporated in Virginia; business address in Germantown, Maryland; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-07).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-07 | Ares Trading Sa | 4.9% |
| Schedule 13G/A, 2026-05-15 | Point72 Asset Management, L.P. | 1.9% |
| Schedule 13D/A, 2026-03-31 | Randal J. Kirk | 35.9% |
| Schedule 13G/A, 2026-02-13 | Patient Capital Management, LLC | 10.2% |
| Schedule 13G, 2026-01-23 | Point72 Asset Management, L.P. | 5.2% |
| Schedule 13D/A, 2025-11-21 | Randal J. Kirk | 38.1% |
| Schedule 13G/A, 2025-10-30 | Patient Capital Management, LLC | 13.6% |
| Schedule 13G, 2025-09-23 | William H. Miller Iii Living Trust Dated April 17, 2017 | 9.2% |
| Schedule 13D/A, 2025-09-19 | Randal J. Kirk | 39.4% |
Questions about who owns Precigen, Inc.
Who owns Precigen, Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Precigen, Inc.: Randal J. Kirk (35.9%, Schedule 13D/A, filed 2026-03-31), Patient Capital Management, LLC (10.2%, Schedule 13G/A, filed 2026-02-13) and William H. Miller Iii Living Trust Dated April 17, 2017 (9.2%, Schedule 13G, filed 2025-09-23).
Who are the largest shareholders of Precigen, Inc.?
By the share each holder's latest filing reports, the largest holders of Precigen, Inc. on this page are Randal J. Kirk (35.9%), Patient Capital Management, LLC (10.2%) and William H. Miller Iii Living Trust Dated April 17, 2017 (9.2%).
When did Randal J. Kirk buy into Precigen, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Randal J. Kirk on this page is the Schedule 13D/A, filed 2025-09-19, reporting 39.4%; its latest, Schedule 13D/A filed 2026-03-31, reports 35.9%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Precigen, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Precigen, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Precigen, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Precigen, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director and 10% owner: 116,301,090 shares (32.4% of shares outstanding), held indirectly through a zsk 2008 (Form 4, 2026-03-31).
- , the chief executive and president: 3,779,521 shares (1.1% of shares outstanding) (Form 4, 2026-08-25).
- , a director: 1,243,239 shares (0.35% of shares outstanding) (Form 4, 2026-03-16).
- , a director: 1,226,391 shares (0.34% of shares outstanding) (Form 4, 2026-03-16).
- , a director: 782,909 shares (0.22% of shares outstanding) (Form 4, 2026-03-16).
Shares outstanding: 358,549,980 as of 2026-10-30, from the company's latest SEC cover page.
How much has Precigen, Inc. raised?
No fundraising or offering filing from Precigen, Inc. is on file with us.
Keep reading
More on Precigen, Inc. and the records around it.
Precigen, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- Patient Capital Management, LLC also filed stake reports on 2 other companies: Dave & Buster's Entertainment, Inc. (May 2026), Canada Goose Holdings Inc. (Aug 2025)
- Point72 Asset Management, L.P. also filed stake reports on 90 other companies: Immunocore Holdings plc (Nov 2026), Target Hospitality Corp. (Nov 2026), E.W. SCRIPPS Co (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/precigen